XML 24 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Common Stock In Treasury
Additional Paid in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at Dec. 31, 2017 $ 530 $ (1,397,962) $ 1,274,811 $ (4,227) $ 1,399,495 $ (380) $ (4,227) $ 1,276,494
Balance (in shares) at Dec. 31, 2017 52,973,000 (28,771,000)            
Increase (Decrease) in Stockholders' Equity                
Stock compensation expense     29,472         29,472
Exercise of stock options $ 4   23,060         $ 23,064
Exercise of stock options (in shares) 409,000             409,208
Issuance of equity $ 1   (698)         $ (697)
Issuance of equity (in shares) 154,000              
Repurchase of stock   $ (63,040)           (63,040)
Repurchase of stock (in shares)   (830,000)            
Net income         24,181     24,181
Other comprehensive income (loss)-other           56   56
Balance at Dec. 31, 2018 $ 535 $ (1,461,002) 1,326,645 (144) 1,419,449 (324) (144) 1,285,303
Balance (in shares) at Dec. 31, 2018 53,536,000 (29,601,000)            
Increase (Decrease) in Stockholders' Equity                
Stock compensation expense     25,501         25,501
Exercise of stock options $ 7   32,708         $ 32,715
Exercise of stock options (in shares) 543,000             543,752
Issuance of equity $ 1   1,762         $ 1,763
Issuance of equity (in shares) 206,000              
Repurchase of stock   $ (3,725)           (3,725)
Repurchase of stock (in shares)   (61,000)            
Net income         55,902     55,902
Other comprehensive income (loss)-other           468   468
Balance at Dec. 31, 2019 $ 543 $ (1,464,727) 1,386,616 $ (412) 1,475,207 144 $ (412) $ 1,397,783
Balance (in shares) at Dec. 31, 2019 54,285,000 (29,662,000)           24,623,000
Increase (Decrease) in Stockholders' Equity                
Stock compensation expense     25,450         $ 25,450
Exercise of stock options $ 11   64,518         $ 64,529
Exercise of stock options (in shares) 1,041,000             1,042,186
Issuance of equity $ 1   635         $ 636
Issuance of equity (in shares) 223,000              
Net income         382,335     382,335
Other comprehensive income (loss)-other           (349)   (349)
Balance at Dec. 31, 2020 $ 555 $ (1,464,727) $ 1,477,219   $ 1,857,130 $ (205)   $ 1,869,972
Balance (in shares) at Dec. 31, 2020 55,549,000 (29,662,000)           25,887,000